TY  - CHAP
M1  - Book, Section
TI  - Chapter 13. Neonatal Jaundice in Low- and Middle-Income Countries
A1  - Slusher, Tina M.
A1  - Olusanya, Bolajoko O.
A2  - Stevenson, David K.
A2  - Maisels, M. Jeffrey
A2  - Watchko, Jon F.
Y1  - 2012
N1  - 
T2  - Care of the Jaundiced Neonate
AB  - For  the  most  part,  in  the  developed  world,  neonatal  jaundice  occurs  without  significant  morbidity  and/or  mortality  due  to  early  diagnosis  and  treatment.1  However,  most  literature  from  low-middle-income  countries  (LMICs)  suggests  that  it  accounts  for  significant  morbidity  and  mortality  in  contrast  to  that  in  the  United  States  and  developed  world  (Table  13-1).2–18  For  example,  based  on  limited  population-based  data  available  worldwide,  severe  neonatal  jaundice  is  about  100-fold  greater  in  Nigeria  than  in  the  developed  world.  In  one  of  the  few  population-based  studies  from  the  developed  world,  Ebbesen  et  al.17  from  Denmark  reported  that  24/100,000  neonates  met  exchange  blood  transfusion  (exchange  transfusion  [ET])  criteria,  while  9/100,000  developed  acute  bilirubin  encephalopathy  (ABE),  in  comparison  to  results  from  the  only  population-based  study  in  Nigeria,  in  which  Olusanya  et  al.  reported  1860/100,000  infants  had  an  EBT.19  Based  on  the  limited  data  available,  ABE  is  at  least  as  common  as  tetanus  as  a  cause  of  neonatal  deaths  in  Nigeria,  Kenya,  and  Pakistan,11,13,20–23  and  likely  in  most  LMICs  often  ranking  as  one  of  the  top  five  causes  of  neonatal  death.8,11,13,24  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesspediatrics.mhmedical.com/content.aspx?aid=56324207
ER  -